By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CardioDx, Inc. 

2500 Faber Place

Palo Alto  California  94303  U.S.A.
Phone: 650-475-2788 Fax: 650-475-2799



Start Up

Company News
CardioDx, Inc. Announces Aetna And Coventry Health Coverage For Corus® CAD Gene Expression Test 7/8/2014 11:49:52 AM
CardioDx, Inc. Release: New Study Results Further Reinforce That The Corus® CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions For Patients With Suspected Obstructive Coronary Artery Disease 5/5/2014 9:52:05 AM
CardioDx, Inc. Resurrects IPO Dreams 4/30/2014 8:18:29 AM
CardioDx, Inc. Announces New Leadership Appointments 4/28/2014 5:13:27 PM
CardioDx, Inc. And Medison Israel Enter Into An Exclusive Corus® CAD Product Marketing And Sales Agreement 4/9/2014 9:41:33 AM
CardioDx, Inc. Release: Study Finds the Corus® CAD Gene Expression Blood Test Influenced Primary Care Decision-Making In The Assessment Of Patients With Suspected Obstructive Coronary Artery Disease 3/11/2014 10:04:37 AM
CardioDx, Inc. Release: The Corus® CAD Gene Expression Test Can Help Commercial Health Plans Reduce Costs By Improving The Accuracy Of The Diagnostic Workup In Patients With Suspected Obstructive Coronary Artery Disease 2/26/2014 12:58:21 PM
CardioDx, Inc. Release: The Corus(R) CAD Gene Expression Test Significantly Correlates With Plaque Burden And Obstructive Coronary Artery Disease As Validated By CT-Angiography 2/3/2014 10:16:48 AM
CardioDx, Inc. Release: Results From REGISTRY 1 Study Confirm Clinical Utility Of Corus® CAD Genomic Test In Optimizing Care In Elderly Patients Presenting To The Primary Care Clinician With Symptoms Suggestive Of Obstructive Coronary Artery Disease 11/25/2013 7:34:27 AM
CardioDx, Inc. Release: New Data Presented At The American Heart Association Scientific Sessions Highlight The Clinical Utility Of The Corus CAD Gene Expression Test In Women And Demonstrate That The Corus CAD Score Correlates With Cardiovascular Outcomes 11/18/2013 11:11:50 AM